SCHEMBL6359949

SCHEMBL6359949

[c]1nc(OCc2ccccc2)nc2scc(-c3ccccc3)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 1/20 0.37
ESR1 P03372 3/20 0.37
DAPK3 O43293 1/20 0.35
PRKD3 O94806 1/20 0.35
MAP4K4 O95819 1/20 0.35
ABL1 P00519 1/20 0.35
NTRK1 P04629 1/20 0.35
LCK P06239 1/20 0.35
CSF1R P07333 1/20 0.35
RET P07949 1/20 0.35
MET P08581 1/20 0.35
PDGFRB P09619 1/20 0.35
FGFR1 P11362 1/20 0.35
PDGFRA P16234 1/20 0.35
PRKACA P17612 1/20 0.35
FLT1 P17948 1/20 0.35
LTK P29376 1/20 0.35
KDR P35968 1/20 0.35
MAP2K2 P36507 1/20 0.35
MAPK8 P45983 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6362941 0.81 MAPT (0.38) SQORDAPK3PRKD3MAP4K4ABL1
SCHEMBL2368787 0.77 CYP1A2 (0.42) SQORESR1DAPK3PRKD3MAP4K4
SCHEMBL6359338 0.76 ESR1 (0.38) ESR1DAPK3PRKD3MAP4K4ABL1
SCHEMBL6364382 0.74 ESR1 (0.45) ESR1DAPK3PRKD3MAP4K4ABL1
SCHEMBL6359795 0.73 ALDH1A1 (0.42) ESR1DAPK3PRKD3MAP4K4ABL1
SCHEMBL5790639 0.71 HTT (0.35) DAPK3PRKD3MAP4K4ABL1NTRK1
SCHEMBL2368948 0.70 ALDH1A1 (0.38) DAPK3PRKD3MAP4K4ABL1NTRK1
SCHEMBL5789324 0.70 FGFR1 (0.35) ESR1DAPK3PRKD3MAP4K4ABL1
SCHEMBL6364115 0.69 HTT (0.41) LMNASMN1; SMN2HPGDMEN1KMT2A
SCHEMBL2368759 0.69 BTK (0.39) ESR1DAPK3PRKD3MAP4K4ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050026935-A1 Compounds XENTION DISCOVERY LTD. 2005-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026935-A1 Compounds KCNJ11, KCNJ1, KCNH1 SQOR 174/4885ESR1 4494/4885DAPK3 2662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.